The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; none of the 32 sources its claims cite is checked for support yet.
YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs
Open accessAbstract
N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic messenger RNA (mRNA) and plays critical roles in RNA biology. The function of this modification is mediated by m6A-selective ‘reader’ proteins of the YTH family, which incorporate m6A-modified mRNAs into pathways of RNA metabolism. Here, we show that the m6A-binding protein YTHDC1 mediates export of methylated mRNA from the nucleus to the cytoplasm in HeLa cells. Knockdown of YTHDC1 results in an extended residence time for nuclear m6A-containing mRNA, with an accumulation of transcripts in the nucleus and accompanying depletion within the cytoplasm. YTHDC1 interacts with the splicing factor and nuclear export adaptor protein SRSF3, and facilitates RNA binding to both SRSF3 and NXF1. This role for YTHDC1 expands the potential utility of chemical modification of mRNA, and supports an emerging paradigm of m6A as a distinct biochemical entity for selective processing and metabolism of mammalian mRNAs.
Overview
CoChat Summary
TL;DR
YTHDC1, a nuclear m6A reader, mediates nuclear-to-cytoplasmic export of methylated mRNAs in HeLa cells by linking m6A recognition to the export adaptor SRSF3 and the export receptor NXF1. Knockdown of YTHDC1 causes nuclear accumulation and cytoplasmic depletion of its target transcripts, independent of pre-mRNA splicing.
Key findings
- Knockdown of YTHDC1 increased nuclear m6A levels and extended the apparent half-life of nuclear mRNA methylation more than 2-fold after transcription inhibition; YTHDF2 knockdown extended cytoplasmic m6A apparent half-life by ~4-fold.
- YTHDC1 knockdown did not change total mRNA m6A/A but caused nuclear accumulation and cytoplasmic depletion of m6A and polyA RNA; overexpression of YTHDC1 after YTHDF2 knockdown increased cytoplasmic m6A.
- YTHDC1 targets were defined as transcripts bound in PAR-CLIP and enriched at least 2-fold in RIP-seq, yielding over 700 targets; upon YTHDC1 knockdown, target abundance increased in nuclear RNA and decreased in cytoplasmic RNA, while total target abundance was unchanged.
- YTHDC1 interacts with SRSF3, and SRSF3 interacts with NXF1; YTHDC1 knockdown reduced m6A enrichment by SRSF3 and abolished m6A enrichment by NXF1. Only transcripts bound by both YTHDC1 and SRSF3 showed significant nuclear accumulation upon YTHDC1 knockdown.
- YTHDC1 knockdown affected alternative splicing, with 426 events at Δpsi ≥0.2; 85/737 (11.5%) occurred in YTHDC1 targets versus 108/4,848 (2.2%) in non-targets, but reporter assays showed export effects independent of splicing and m6A binding.
Methods
- HeLa cells were used for siRNA knockdown, plasmid transfection, cellular fractionation, and RNA isolation; m6A/A was quantified by LC-MS/MS on polyA-selected, ribosomal RNA-depleted mRNA from total, nuclear, and cytoplasmic fractions.
- RNA substrates were identified by YTHDC1 PAR-CLIP and RIP-seq, subcellular transcriptomes by RNA-seq after YTHDC1 knockdown, and binding by SRSF3/NXF1 by CLIP or RIP followed by LC-MS/MS and sequencing.
- Mechanistic tests included endogenous and FLAG immunoprecipitation, western blotting, polyA FISH, nascent RNA labeling with 5-ethynyl uridine, RT-qPCR, and a Tet-inducible BoxB-luciferase reporter tethering assay with full-length, N-terminal, C-terminal, and W377A YTHDC1 constructs.
Limitations
- The paper does not include a dedicated limitations section.
- Evident from the text: most experiments are in HeLa cells, so generality to other cell types or organisms is not established.
- The m6A/A measurements are ensemble bulk measurements; the paper notes this allows relative clearance comparisons without determining absolute half-lives of individual mRNAs.
- Export conclusions rely heavily on knockdown/overexpression and tethering assays; the reporter system is splicing-independent and methylation-independent due to BoxB–lambda peptide binding, which the authors present as an advantage but which also means it does not test endogenous m6A-dependent export directly.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



















Verification
Claims the paper makes
0 Valid · 0 Not valid · 19 Not checked · 124 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Upon knockdown of YTHDC1, we observed nuclear accumulation of nascent mRNA for both APC and MCL1 transcripts compared to control, whereas the difference in nuclear SOX12 mRNA abundance was modest and not significant in our assay (Figure 4A).”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 mediates nuclear export of nascent mRNA
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We show that upon knockdown of YTHDC1, mature mRNA localization is perturbed independently of a splicing requirement or splicing outcomes.”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Discussion > m6A selectivity in nuclear mRNA processing and export
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We observed enrichment of m6A in mRNA bound by SRSF3 under both conditions.”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 facilitates RNA binding to SRSF3 and NXF1
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although YTHDC1 interacts with SRSF3, we did not observe any direct interaction between YTHDC1 and the export receptor NXF1, nor did we observe interaction between YTHDC1 and the common mRNA adaptor protein ALYREF (Figure 5A).”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 bridges m6A selectivity to mRNA export via SRSF3
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knockdown of YTHDC1 does not affect the m6A/A ratio in mRNA transcripts from whole cell lysate, but results in accumulation of m6A in nuclear mRNA and in an accompanying cytoplasmic depletion of m6A levels (Figure 2A).”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 mediates nuclear to cytoplasmic transport of methylated mRNAs
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
82 more claims
Create a free account to see all 143 claims and to verify the 17 references still open.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 35
- The quote only partly states this claim. 1
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,167
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012) · Nature · doi:10.1038/nature11112 · Cited by 4,884
N6-methyladenosine-dependent regulation of messenger RNA stability
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558 · cited 5×
“Firefly luciferase was fused to five copies of the BoxB sequence and placed under control of a Tet-off promoter (Wang et al., 2014a).”
BackgroundMethodInfluentialSelf-citationALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., Vågbø, C. B., Shi, Y., Wang, W.-L., Song, S.-H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.015 · Cited by 3,550
Self-citation
Cited by
Items 201–300 of 1,260
Wei, G., Almeida, M., Pintacuda, G., Coker, H. A., Bowness, J. S., Ule, J., & Brockdorff, N. (2021) · Genome Research · doi:10.1101/gr.271635.120 · Cited by 76
Li, W., Ye, K., Li, X., Liu, X., Peng, M., Chen, F., Xiong, W., Wang, Y., & Zhu, L. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02460-9 · Cited by 75
Yang, J.-G., Sun, B., Wang, Z., Li, X., Gao, J.-H., Qian, J., Li, J., Wei, W.-J., Zhang, P., & Wang, W. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06263-4 · Cited by 75
Tan, B., & Gao, S. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.1983 · Cited by 74
Zhang, Z., Wang, Q., Zhang, M., Zhang, W., Zhao, L., Yang, C., Wang, B., Jiang, K., Ye, Y., Shen, Z., et al. (2020) · Epigenetics · doi:10.1080/15592294.2020.1805684 · Cited by 74
Self-citationLiu, X., Qin, J., Gao, T., Li, C., He, B., Pan, B., Xu, X., Chen, X., Zeng, K., Xu, M., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.09.036 · Cited by 74
RetractedDysregulated mitochondrial and cytosolic tRNA m1A methylation in Alzheimer’s disease
Shafik, A. M., Zhou, H., Lim, J.-H., Dickinson, B. C., & Jin, P. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab357 · Cited by 74
Li, G., Luo, R., Zhang, W., He, S., Wang, B., Liang, H., Song, Y., Ke, W., Shi, Y., Feng, X., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.765 · Cited by 74
AKT kinases as therapeutic targets
Hassan, D., Menges, C. W., Testa, J. R., & Bellacosa, A. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03207-4 · Cited by 74
Emerging Roles of SRSF3 as a Therapeutic Target for Cancer
Zhou, Z., Gong, Q., Lin, Z., Wang, Y., Li, M., Wang, L., Ding, H., & Li, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.577636 · Cited by 73
Epigenetic regulations in mammalian spermatogenesis: RNA-m6A modification and beyond
Gui, Y., & Yuan, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03823-9 · Cited by 73
Li, E., Xia, M., Du, Y., Long, K., Ji, F., Pan, F., He, L., Hu, Z., & Guo, Z. (2022) · eLife · doi:10.7554/elife.75231 · Cited by 73
Jones, J. D., Monroe, J. G., & Koutmou, K. S. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1586 · Cited by 73
RNA N6-Methyladenosine Responds to Low-Temperature Stress in Tomato Anthers
Yang, D., Xu, H., Liu, Y., Li, M., Ali, M., Xu, X., & Lu, G. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.687826 · Cited by 72
Epitranscriptomic addition of m 6 A regulates HIV-1 RNA stability and alternative splicingPreprint
Tsai, K., Bogerd, H. P., Kennedy, E. M., Emery, A., Swanstrom, R. I., & Cullen, B. R. (2021) · Genes & Development · doi:10.1101/gad.348508.121 · Cited by 72
Functional interdependence of N6-methyladenosine methyltransferase complex subunits in Arabidopsis
Shen, L. (2023) · The Plant Cell · doi:10.1093/plcell/koad070 · Cited by 71
Shriwas, O., Mohapatra, P., Mohanty, S., & Dash, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612337 · Cited by 70
RNA modification systems as therapeutic targets
Zhang, L., Wei, J., Zou, Z., & He, C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01280-8 · Cited by 70
Self-citationN6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies
Tan, F., Zhao, M., Xiong, F., Wang, Y., Zhang, S., Gong, Z., Li, X., He, Y., Shi, L., Wang, F., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01952-4 · Cited by 69
Tan, B., Zhou, K., Liu, W., Prince, E. A., Qing, Y., Li, Y., Han, L., Qin, X., Su, R. J., Pokharel, S. P., et al. (2022) · Theranostics · doi:10.7150/thno.71872 · Cited by 69
Self-citationAberrant Regulation of mRNA m6A Modification in Cancer Development
Luo, J., Liu, H., Luan, S., He, C., & Li, Z. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092515 · Cited by 68
Self-citationEpitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions
Imam, H., Kim, G., & Siddiqui, A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.584283 · Cited by 68
Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers
Dai, X., Shi, L., Li, Z., Yang, H., Wei, J., & Ding, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.635329 · Cited by 67
Xu, J., Cai, Y., Ma, Z., Jiang, B., Liu, W., Cheng, J., Guo, N., Wang, Z., Sealy, J. E., Song, C., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009530 · Cited by 66
Self-citationEmerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases
Xu, Z., Lv, B., Qin, Y., & Zhang, B. (2022) · Cells · doi:10.3390/cells11071101 · Cited by 66
Chen, Z., Song, J., Xie, L., Xu, G., Zheng, C., Xia, X., Lu, F., Ma, X., Zou, F., Jiang, J., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01190-5 · Cited by 66
RNA methylation in nuclear pre‐mRNA processing
Molares, H. C., Bartošovič, M., & Vaňáčová, Š. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1489 · Cited by 66
Detection of N6‑methyladenosine modification residues (Review)
Zhu, W., Wang, J., Xu, Z., Cao, M., Hu, Q., Chen, P., Guo, M., Wei, J., & Yang, H. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4169 · Cited by 66
Chen, J., Fang, X., Zhong, P., Song, Z., & Hu, X. (2019) · RNA Biology · doi:10.1080/15476286.2019.1620060 · Cited by 66
The m6A pathway protects the transcriptome integrity by restricting RNA chimera formation in plants
Pontier, D., Picart, C., Baidouri, M. E., Roudier, F., Xu, T., Lahmy, S., Llauro, C., Azevedo, J., Laudié, M., Attina, A., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900393 · Cited by 66
Association of N6-methyladenosine with viruses and related diseases
Wu, F., Cheng, W., Zhao, F., Tang, M., Diao, Y., & Xu, R. (2019) · Virology Journal · doi:10.1186/s12985-019-1236-3 · Cited by 66
Wang, L., Xue, Y., Li, H., Huo, R., Yan, Z., Wang, J., Xu, H., Wang, J., Cao, Y. B., & Zhao, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15101 · Cited by 65
m 6 A modification patterns and tumor immune landscape in clear cell renal carcinoma
Zhong, J., Liu, Z., Cai, C., Duan, X., Deng, T., & Zeng, G. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001646 · Cited by 64
Nair, L., Zhang, W., Laffleur, B., Jha, M. K., Lim, J., Lee, H. J., Wu, L., Alvarez, N. S., Liu, Z., Munteanu, E. L., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.037 · Cited by 64
Zhao, Y., Li, Y., Zhu, R., Feng, R., Cui, H., Xiao, Y., Huang, F., Zhang, R., Chen, X., Li, L., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01428-1 · Cited by 64
Hoernes, T. P., Heimdörfer, D., Kostner, D., Faserl, K., Nußbaumer, F., Plangger, R., Kreutz, C., Lindner, H., & Erlacher, M. D. (2019) · Genes · doi:10.3390/genes10020084 · Cited by 64
Diverse molecular functions of m6A mRNA modification in cancer
Han, S. H., & Choe, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0432-y · Cited by 63
Kim, G., Imam, H., & Siddiqui, A. (2021) · Journal of Virology · doi:10.1128/jvi.00097-21 · Cited by 63
Readers of the m6A epitranscriptomic code
Berlivet, S., Scutenaire, J., Deragon, J., & Bousquet‐Antonelli, C. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.12.008 · Cited by 63
Wang, Y., Wang, H., Xi, F., Wang, H., Han, X., Wei, W., Zhang, H., Zhang, Q., Zheng, Y., Zhu, Q., et al. (2020) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13002 · Cited by 63
Chen, X., Wang, J., Tahir, M., Zhang, F., Ran, Y., Liu, Z., & Wang, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00661-x · Cited by 62
Role of N6-methyladenosine modification in pathogenesis of ischemic stroke
Chang, H., Jun, Y., Wang, Q., Zhao, J., & Zhu, R. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2049246 · Cited by 62
Effects of writers, erasers and readers within miRNA‐related m6A modification in cancers
Feng, H., Yuan, X., Wu, S., Yuan, Y., Cui, L., Lin, D., Peng, X., Liu, X., & Wang, F. (2022) · Cell Proliferation · doi:10.1111/cpr.13340 · Cited by 62
Adenosine methylation as a molecular imprint defining the fate of RNA
Knuckles, P., & Bühler, M. (2018) · FEBS Letters · doi:10.1002/1873-3468.13107 · Cited by 62
Chromatin and transcriptional regulation by reversible RNA methylation
Wei, J., & He, C. (2021) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2020.11.005 · Cited by 62
Self-citationThe potential role of m6A RNA methylation in diabetic retinopathy
Kumari, N., Karmakar, A., Khan, M. M. A., & Ganesan, S. K. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108616 · Cited by 60
A single m6A modification in U6 snRNA diversifies exon sequence at the 5’ splice site
Ishigami, Y., Ohira, T., Isokawa, Y., Suzuki, Y., & Suzuki, T. (2021) · Nature Communications · doi:10.1038/s41467-021-23457-6 · Cited by 60
The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer
Shi, B., Liu, W.-W., Yang, K., Jiang, G., & Wang, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01634-5 · Cited by 60
Zhang, J., Wei, J., Sun, R., Sheng, H., Yin, K., Pan, Y., Jiménez, R. E., Chen, S., Cui, X., Zou, Z., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.024 · Cited by 60
Self-citationLi, J., Chen, F., Peng, Y., Lv, Z., Lin, X., Chen, Z., & Wang, H. (2020) · Cells · doi:10.3390/cells9020296 · Cited by 60
Dynamic and reversible RNA N6‐methyladenosine methylation
Duan, H., Wang, Y., & Jia, G. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1507 · Cited by 59
The m6A‑methylase complex and mRNA export
Lesbirel, S., & Wilson, S. A. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.09.008 · Cited by 59
Metabolic Control of m6A RNA Modification
Kim, J., & Lee, G. (2021) · Metabolites · doi:10.3390/metabo11020080 · Cited by 59
Regulatory role and mechanism of m6A RNA modification in human metabolic diseases
Zhang, Y., Chen, W., Zheng, X., Guo, Y., Cao, J., Zhang, Y., Wen, S., Gao, W., & Wu, Y. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.05.003 · Cited by 59
A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells
Porman, A. M., Roberts, J. T., Duncan, E. D., Chrupcala, M. L., Levine, A. A., Kennedy, M. A., Williams, M. M., Richer, J. K., & Johnson, A. M. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001885 · Cited by 58
Dai, C., Tang, Y., Yang, H., & Zheng, J. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.06.017 · Cited by 58
m6A mRNA Destiny: Chained to the rhYTHm by the YTH-Containing Proteins
Hazra, D., Chapat, C., & Graille, M. (2019) · Genes · doi:10.3390/genes10010049 · Cited by 58
RNA N6-Methyladenosine and the Regulation of RNA Localization and Function in the Brain
Madugalle, S. U., Meyer, K. D., Wang, D. O., & Bredy, T. W. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.09.005 · Cited by 58
N6-Adenosine Methylation (m6A) RNA Modification: an Emerging Role in Cardiovascular Diseases
Chen, Y., Ouyang, X.-P., Yu, X.-H., Novák, P., Zhou, L., He, P., & Yin, K. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10108-w · Cited by 58
Qin, S., Mao, Y., Wang, H., Duan, Y., & Zhao, L. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60641 · Cited by 57
m6A RNA modification in transcription regulation
Akhtar, J., Lugoboni, M., & Junion, G. (2021) · Transcription · doi:10.1080/21541264.2022.2057177 · Cited by 57
RNA modifications in cardiovascular health and disease
Gatsiou, A., & Stellos, K. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00804-8 · Cited by 57
Hao, S.-H., Ma, X., Xu, L., Xie, J., Feng, Z., Chen, R., Chen, R.-X., Tang, Y., Tang, Y., Xie, D., et al. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101052 · Cited by 57
RNA tales – how embryos read and discard messages from mom
Despic, V., & Neugebauer, K. M. (2018) · Journal of Cell Science · doi:10.1242/jcs.201996 · Cited by 57
Li, J., Pei, Y., Zhou, R., Tang, Z., & Yang, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56251 · Cited by 57
Gu, C., Shi, X., Qiu, W., Huang, Z., Yu, Y., Shen, F., Chen, Y., & Pan, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.661792 · Cited by 56
Liu, T., Zheng, X., Wang, C., Wang, C., Jiang, S., Li, B., Chen, P., Xu, W., Zheng, H., Yang, R., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04312-4 · Cited by 56
Self-citationLi, J., Xie, G., Tian, Y., Li, W., Wu, Y., Chen, F., Lin, Y., Lin, X., Au, S. W.-N., Cao, J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.019 · Cited by 56
m6A Methylation in Cardiovascular Diseases: From Mechanisms to Therapeutic Potential
Li, L., Xu, N., Liu, J., Chen, Z., Liu, X., & Wang, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.908976 · Cited by 56
The role of RNA m6A methylation in lipid metabolism
Wang, Y., Wang, Y., Gu, J., Su, T., Gu, X., & Feng, Y. Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.866116 · Cited by 56
Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis
Islam, R., Zhao, L., Wang, Y.-F., Lu-Yao, G. L., & Liu, L.-Z. (2022) · Cancers · doi:10.3390/cancers14184502 · Cited by 56
Wang, L.-J., Xue, Y., Huo, R., Yan, Z., Xu, H., Li, H., Jia, W., Zhang, Q., Cao, Y. B., & Zhao, J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00655-w · Cited by 56
m6A: Widespread regulatory control in virus replication
Manners, O., Baquero-Pérez, B., & Whitehouse, A. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.10.015 · Cited by 55
N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology
Wu, J., Guo, X., Wen, Y., Huang, S.-Q., Yuan, X., Tang, L., & Sun, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.709299 · Cited by 55
Emerging roles of m6A RNA modification in cancer therapeutic resistance
Liu, W., Zhang, Z., Wang, F., & Wang, H. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00386-2 · Cited by 55
Self-citationEpitranscriptomics in metabolic disease
Matsumura, Y., Wei, F., & Sakai, J. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00764-4 · Cited by 55
Small molecule inhibitors targeting m6A regulators
Feng, G., Wu, Y., Hu, Y., Wen, S., Yang, X. J., Li, Y., Ouyang, L., & Wang, G. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01546-5 · Cited by 55
The emerging roles of N6-methyladenosine RNA methylation in human cancers
Shen, H., Lan, Y., Zhao, Y., Shi, Y., Jin, J., & Xie, W. (2020) · Biomarker Research · doi:10.1186/s40364-020-00203-6 · Cited by 55
Jones, A. N., Tikhaia, E., Mourão, A., & Sattler, M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac080 · Cited by 55
Fang, X., Li, M., Yu, T., Liu, G., & Wang, J. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.06.011 · Cited by 54
RNA N6-methyladenosine modification in female reproductive biology and pathophysiology
Huang, E., & Chen, L. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01078-4 · Cited by 54
Mechanism of N6-methyladenosine modification and its emerging role in cancer
Zhang, S. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.04.011 · Cited by 54
Wu, Y., Liu, W., Chen, J., Liu, S., Wang, M., Yang, L., Chen, C., Qi, M., Xu, Y., Qiao, Z., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.055 · Cited by 54
Self-citationFang, Z., Hu, Y., Hu, J., Huang, Y., Zheng, S. S., & Guo, C. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00583-8 · Cited by 53
From A to m6A: The Emerging Viral Epitranscriptome
Baquero-Pérez, B., Geers, D., & Díez, J. (2021) · Viruses · doi:10.3390/v13061049 · Cited by 53
RNA modifications in hematopoietic malignancies: a new research frontier
Qing, Y., Su, R. J., & Chen, J. (2021) · Blood · doi:10.1182/blood.2019004263 · Cited by 53
RNA m 6 A methylation in cancer
Wang, Z., Zhou, J., Zhang, H., Ge, L., Li, J., & Wang, H. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13326 · Cited by 53
N1-methyladenosine formation, gene regulation, biological functions, and clinical relevance
Xiong, W., Zhao, Y., Wei, Z., Li, C., Zhao, R., Ge, J., & Shi, B. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.10.015 · Cited by 53
Functional Implications of Active N6-Methyladenosine in Plants
Zheng, H., Li, S., Zhang, X., & Sui, N. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00291 · Cited by 53
Li, P., Shi, Y., Gao, D., Xu, H., Zou, Y., Wang, Z., & Li, W. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.75063 · Cited by 53
Reshaping the role of m6A modification in cancer transcriptome: a review
Yang, G., Sun, Z., & Zhang, N. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01445-y · Cited by 52
Molares, H. C., Obrdlík, A., Poštulková, I., Dohnálková, M., Gregorová, P., Ganji, R. S., Potěšil, D., Gawriyski, L. M., Varjosalo, M. T., & Vaňáčová, Š. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab900 · Cited by 52
Ottesen, E. W., Singh, N. N., Luo, D., Kaas, B., Gillette, B., Seo, J., Jorgensen, H. J., & Singh, R. N. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad259 · Cited by 52
The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing
Wen, T., Li, T., Xu, Y., Zhang, Y., Pan, H., & Wang, Y. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01385-w · Cited by 52
Tang, T. J., Han, Y., Wang, Y., Huang, H., & Qian, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.677587 · Cited by 52
Small Molecule-Inducible RNA-Targeting Systems for Temporal Control of RNA Regulation
Rauch, S., Jones, K. A., & Dickinson, B. C. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00537 · Cited by 51
Tian, S., Lai, J., Yu, T., Li, Q., & Chen, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.623634 · Cited by 51
The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research
Song, N., Cui, K., Zhang, K., Yang, J., Liu, J., Miao, Z., Zhao, F., Meng, H., Chen, L., Chen, C., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.933332 · Cited by 51
It's complicated… m6A-dependent regulation of gene expression in cancer
Fitzsimmons, C. M., & Batista, P. J. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.09.010 · Cited by 51
N6-Methyladenosine: A Potential Breakthrough for Human Cancer
Liu, L., Wang, Y., Wu, J., Liu, J., Qin, Z., & Fan, H. B. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.013 · Cited by 51
Metadata
- Authors
- Roundtree, I. A., Luo, G.-Z., Zhang, Z., Wang, X., Zhou, T., Cui, Y., Sha, J., Huang, X., Guerrero, L., Xie, P., He, E., Shen, B., & He, C.
- Affiliations
- Howard Hughes Medical Institute (US)
- ShanghaiTech University (CN)
- State Key Laboratory of Reproductive Medicine (CN)
- University of Chicago (US)
- Corresponding author
- Shen, Bin
- He, Chuan
- ORCID
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2017-10-06
- Volume
- 6
- ISSN
- 2050-084X (ISSN-L)
- PMC
- PMC5648532
- OpenAlex
- W2764301500
- Cited by
- 1,256
- References
- 59
- Citations by year
- 2026: 99 · 2025: 163 · 2024: 199 · 2023: 198 · 2022: 201 · 2021: 181 · 2020: 114 · 2019: 57 · 2018: 43
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- eLife (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Chicago (cc-by)
- Funders
- National Institute of General Medical Sciences (F30GM117646, HG008688, GM113194)
- Howard Hughes Medical Institute
- National Science Foundation (CHE-1048528)
- National Natural Science Foundation of China (31171377, 31471400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- YTHDC1, N6-methyladenosine, m6A reader proteins, mRNA export, mRNA splicing, SRSF3, NXF1, mRNA modification, RNA metabolism
- MeSH terms
- Serine-Arginine Splicing Factors, RNA Splicing Factors, Adenosine, HeLa Cells, Humans, Nerve Tissue Proteins, Protein Binding, RNA, Messenger, RNA-Binding Proteins, Active Transport, Cell Nucleus, Nucleocytoplasmic Transport Proteins, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-13, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-13 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.